EMEA-001741-PIP01-14-M01

  • Email
  • Help

Overview

Product details for -
Invented name-
Active substance

Upadacitinib

Decision numberP/0363/2017
PIP numberEMEA-001741-PIP01-14-M01
Pharmaceutical form(s)Age-appropriate oral solid dosage form, Tablet
Condition(s)/indication(s)

Treatment of chronic idiopathic arthritis (including rheumatoid arthritis, psoriatic arthritis, spondyloarthritis and juvenile idiopathic arthritis)

Route(s) of administrationOral use
PIP applicant

AbbVie Ltd
Tel.: +44 1628408248
E-mail: paediatricteam@abbvie.com

Decision typeP: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision